Freeport Financial LLC received approval yesterday to take drug investigator Cetero Research out of chapter 11 with a revamped balance sheet, Dow Jones DBR Small Cap reported today. Bankruptcy Judge Kevin Carey signed off on the sale of the company under a deal that swaps out about $60 million in first-lien debt for equity.
